Wolverine Blend (BPC-157 + TB-500)

Combined BPC-157 and TB-500 for tissue repair support.

Overview

The Wolverine Blend combines BPC-157 and TB-500 in a single formulation. The rationale is that each compound is proposed to support tissue repair through different mechanisms. Combination data in humans is not available. All preclinical caveats for both individual compounds apply.

Mechanism

See individual BPC-157 and TB-500 descriptions. Additive or synergistic effects in humans have not been studied in controlled trials.

Clinical Considerations

• Prescribed when a provider determines both compounds are appropriate.
• All preclinical limitations of both compounds apply.
• Requires provider evaluation.

Potential Side Effects

• Injection site reactions — expected with any SubQ injection protocol.
• Side effects of both individual compounds may apply — see BPC-157 and TB-500 descriptions.
• Combination human safety data is very limited.

All prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.